Plexus Corp. (NASDAQ:PLXS) Shares Sold by Boston Trust Walden Corp

Boston Trust Walden Corp cut its position in Plexus Corp. (NASDAQ:PLXS - Free Report) by 1.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 384,284 shares of the technology company's stock after selling 6,954 shares during the period. Boston Trust Walden Corp owned 1.42% of Plexus worth $60,133,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of PLXS. Pacer Advisors Inc. purchased a new position in Plexus in the fourth quarter valued at $107,489,000. GSA Capital Partners LLP purchased a new stake in Plexus during the third quarter worth approximately $899,000. Victory Capital Management Inc. boosted its holdings in Plexus by 3.9% in the third quarter. Victory Capital Management Inc. now owns 200,186 shares of the technology company's stock valued at $27,367,000 after purchasing an additional 7,483 shares in the last quarter. Schaper Benz & Wise Investment Counsel Inc. WI boosted its holdings in Plexus by 62.6% in the third quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 13,346 shares of the technology company's stock valued at $1,825,000 after purchasing an additional 5,138 shares in the last quarter. Finally, Stifel Financial Corp purchased a new position in Plexus in the third quarter valued at approximately $332,000. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

PLXS has been the subject of several research analyst reports. Needham & Company LLC upped their target price on shares of Plexus from $162.00 to $172.00 and gave the company a "buy" rating in a report on Friday, January 24th. KeyCorp started coverage on shares of Plexus in a research note on Tuesday, October 22nd. They issued a "sector weight" rating for the company. Stifel Nicolaus assumed coverage on Plexus in a research report on Tuesday. They set a "hold" rating and a $152.00 target price on the stock. Benchmark reissued a "buy" rating and issued a $165.00 target price on shares of Plexus in a research report on Wednesday, January 22nd. Finally, StockNews.com raised Plexus from a "hold" rating to a "buy" rating in a research report on Monday, November 18th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $163.00.

Insider Transactions at Plexus

In related news, CAO Angelo Michael Ninivaggi, Jr. sold 3,423 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $145.14, for a total value of $496,814.22. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company's stock, valued at approximately $4,281,775.14. This trade represents a 10.40 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Todd P. Kelsey sold 4,337 shares of the company's stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $142.23, for a total transaction of $616,851.51. Following the sale, the chief executive officer now directly owns 80,595 shares of the company's stock, valued at approximately $11,463,026.85. This trade represents a 5.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,239 shares of company stock worth $2,212,730 over the last ninety days. 1.76% of the stock is currently owned by corporate insiders.

Plexus Stock Performance

Shares of NASDAQ:PLXS traded down $0.44 on Thursday, reaching $141.95. The company's stock had a trading volume of 197,940 shares, compared to its average volume of 181,331. Plexus Corp. has a 52-week low of $90.18 and a 52-week high of $172.89. The stock has a market capitalization of $3.84 billion, a P/E ratio of 32.94 and a beta of 0.89. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The stock's 50-day moving average is $159.02 and its two-hundred day moving average is $143.55.

Plexus (NASDAQ:PLXS - Get Free Report) last posted its earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. As a group, sell-side analysts forecast that Plexus Corp. will post 5.97 EPS for the current year.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.